BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14764640)

  • 21. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions.
    Lee R; Neya K; Svizzero TA; Vlahakes GJ
    J Appl Physiol (1985); 1995 Jul; 79(1):236-42. PubMed ID: 7559226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood Component Requirements and Erythrocyte Transfusion and Mortality Related to Hemoglobin Deficit in Phase III Trial of Hemoglobin-Based Oxygen Carrier: HBOC-201.
    Jahr JS; Williams JP
    Am J Ther; 2022 May-Jun 01; 29(3):e279-e286. PubMed ID: 35421008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autologous transfusion - from euphoria to reason: clinical practice based on scientific knowledge. (Part IV). Artificial oxygen carriers: cell-free hemoglobin solutions -- current status 2004].
    Standl T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Jan; 40(1):38-45. PubMed ID: 15645386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and mechanisms of plasma removal of hemoglobin-based oxygen carriers.
    Estep TN
    Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):203-15. PubMed ID: 26024447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HemoCue, a point of care B-hemoglobin photometer, measures hemoglobin concentrations accurately when mixed in vitro with canine plasma and three hemoglobin-based oxygen carriers (HBOC).
    Jahr JS; Lurie F; Driessen B; Davis JA; Gosselin R; Gunther RA
    Can J Anaesth; 2002 Mar; 49(3):243-8. PubMed ID: 11861341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the acute hemodynamic and delayed effects of 50% exchange transfusion with two different cross-linked hemoglobin based oxygen carrying solutions and Pentastarch.
    Bonegio RG; Fuhro R; Ragno G; Robert Valeri C; Lieberthal W
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):145-57. PubMed ID: 16537171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Numerical simulation of oxygen delivery to muscle tissue in the presence of hemoglobin-based oxygen carriers.
    Patton JN; Palmer AF
    Biotechnol Prog; 2006; 22(4):1025-49. PubMed ID: 16889379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactate measurement interference by hemoglobin-based oxygen carriers (Oxyglobin, Hemopure, and Hemolink).
    Jahr JS; Osgood S; Rothenberg SJ; Li QL; Butch AW; Gunther R; Cheung A; Driessen B
    Anesth Analg; 2005 Feb; 100(2):431-436. PubMed ID: 15673871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysical properties of tense quaternary state polymerized human hemoglobins bracketed between 500 kDa and 0.2 μm in size.
    Cuddington CT; Wolfe SR; Palmer AF
    Biotechnol Prog; 2022 Jan; 38(1):e3219. PubMed ID: 34626100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Hemopure on maximal oxygen uptake and endurance performance in healthy humans.
    Ashenden MJ; Schumacher YO; Sharpe K; Varlet-Marie E; Audran M
    Int J Sports Med; 2007 May; 28(5):381-5. PubMed ID: 17024639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Hemoglobin-based oxygen carriers to stored human red blood cells.
    Eastman AL; Minei JP
    Crit Care Clin; 2009 Apr; 25(2):303-10, Table of Contents. PubMed ID: 19341910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial.
    Sprung J; Kindscher JD; Wahr JA; Levy JH; Monk TG; Moritz MW; O'Hara PJ
    Anesth Analg; 2002 Apr; 94(4):799-808, table of contents. PubMed ID: 11916776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests.
    Ma Z; Monk TG; Goodnough LT; McClellan A; Gawryl M; Clark T; Moreira P; Keipert PE; Scott MG
    Clin Chem; 1997 Sep; 43(9):1732-7. PubMed ID: 9299968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics of hemoglobin-based oxygen carrier hemoglobin glutamer-200 bovine in the horse.
    Soma LR; Uboh CE; Guan F; Luo Y; Moate PJ; Boston RC; Driessen B
    Anesth Analg; 2005 Jun; 100(6):1570-1575. PubMed ID: 15920176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemoglobin-Based Oxygen Carrier (HBOC) Development in Trauma: Previous Regulatory Challenges, Lessons Learned, and a Path Forward.
    Keipert PE
    Adv Exp Med Biol; 2017; 977():343-350. PubMed ID: 28685464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss.
    Levy JH
    Expert Opin Biol Ther; 2003 Jun; 3(3):509-17. PubMed ID: 12783619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel hemoglobin particles--promising new-generation hemoglobin-based oxygen carriers.
    Bäumler H; Xiong Y; Liu ZZ; Patzak A; Georgieva R
    Artif Organs; 2014 Aug; 38(8):708-14. PubMed ID: 24962099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical considerations in the development of hemoglobin-based oxygen therapeutics.
    Kim HW; Estep TN
    Curr Drug Discov Technol; 2012 Sep; 9(3):212-23. PubMed ID: 21726184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial oxygen carriers--the new doping threat in endurance sport?
    Schumacher YO; Schmid A; Dinkelmann S; Berg A; Northoff H
    Int J Sports Med; 2001 Nov; 22(8):566-71. PubMed ID: 11719891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.